The Inhibitory Activity of Secondary Metabolites Produced by Baker’s Yeast Against Pathogenic Bacteria Isolated from Wound and Burn Infections
Main Article Content
Abstract
Fifty clinical bacterial isolates were collected from wound and burn injuries. Microscopic and culture examinations, including VITEK analysis, confirmed 20 pathogenic isolates of Pseudomonas aeruginosa and 20 pathogenic isolates of Staphylococcus aureus. These isolates were obtained from Ibn Al-Baladi Hospital, Imam Ali Hospital, and Sheikh Dhari Al-Fayyad Hospital. Commercial dry baker's yeast, obtained from local markets, was used. These included isolate 1B from Angel yeast of Chinese origin, isolate 2B from Mill brand yeast of Chinese origin, isolate 3B from saf-instant yeast of French origin, isolate 4B from Delipan yeast of Chinese origin, isolate 5B from XPOWER yeast of Iranian origin, isolate 6B from Bakmaya yeast of Turkish origin, and isolate 7B from Gloripan yeast of Chinese origin. The identification of the isolates was confirmed through biochemical tests and VITEK2 system identification. The susceptibility of the pathogenic bacteria to 20 antibiotics was tested, and the results showed that most bacterial isolates were resistant to the antibiotics, while the other half showed varying susceptibility to the remaining antibiotics. S. cerevisiae yeast isolates were screened to select the isolate most efficient in producing inhibitory secondary metabolites using the pit diffusion method. The results showed that isolate 1B exhibited the highest inhibition rate against both Staphylococcus aureus and Pseudomonas aeruginosa.
Article Details

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.